Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Vanda Pharmaceuticals, Inc.
(NQ:
VNDA
)
11.23
USD
-0.32 (-2.77%)
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Vanda Pharmaceuticals, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Vanda Presents Positive Data from Phase 3 Tasimelteon Study
June 17, 2013
Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ) presented additional data today at ENDO 2013, the Endocrine Society's 95th Annual Meeting, demonstrating that tasimelteon can entrain (synchronize)...
Read More
category
Contracts
,
Management
,
Benzinga
, and 4 more.
from
Latest Articles from Benzinga.com
Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
June 17, 2013
Data presented at ENDO 2013, the Endocrine Society's 95th Annual Meeting
Read More
from
PR Newswire
Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) and Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) Added to Growing Stock Report's NASDAQ Active Stock Watch List.
June 13, 2013
New York, NY -- (SBWIRE) -- 06/13/2013 -- Growing Stock Report expands its NASDAQ Active Stock Watch List adding Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) and Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA).
Read More
from
SBWire - Latest Press Releases
Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) and Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) Added to Equity Profile Report's NASDAQ Active Stock Watch List.
June 13, 2013
Wilmington, DE -- (SBWIRE) -- 06/13/2013 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) and Vanda Pharmaceuticals, Inc....
Read More
from
SBWire - Latest Press Releases
52 WEEK HIGH STOCKS: Sonic Corporation, Spectra Energy Corp., Vanda Pharmaceuticals Inc., West Corp
June 12, 2013
Las Vegas, NV -- (SBWIRE) -- 06/12/2013 -- 52 Week High Stocks provides its subscribers with a free newsletter that reports up to the minute information and exclusive charts on cheap, undervalued,...
Read More
from
SBWire - Latest Press Releases
Shares with Uncommon Trading (VNDA, SCTY, QCOR, BIIB)
June 12, 2013
New York, NY -- (SBWIRE) -- 06/12/2013 -- Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) Far out of the cash contact purchasing on Vanda Medication these days indicates some investors are placement for...
Read More
from
SBWire - Latest Press Releases
Put Options Active On AmerisourceBergen
June 11, 2013
Today’s tickers: ABC, VNDA & DMND ABC - AmerisourceBergen Corp – Shares in AmerisourceBergen are up 2.4% today and nearly 30% year to date, but options in play on the stock suggest one or more...
Read More
category
ABC
,
DMND
,
VNDA
, and 1 more.
from
Phil’s Stock World
Disappointment With BOJ Sends Markets Plunging
June 11, 2013
Disappointment with the Bank of Japan's monetary policy sent the markets tumbling to a sharply lower close with the Dow plunging 116 points to 15,122. Nasdaq plummeted 36 points to 3436.
Read More
category
Market News
from
MarketMinute.com Market Updates
Vanda (VNDA) Strength Continues Following Raised Hedge Fund Stake
June 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8406925 for the full story.
Read More
from
StreetInsider.com News Articles
Benzinga's Volume Movers
June 11, 2013
Dole Food Company (NYSE: DOLE ) shares climbed 21.67% to $12.40. The volume of Dole Food shares traded was 3472% higher than normal. Dole Food shares surged on CEO bid for remaining shares. Diamond...
Read More
category
volume movers
,
Benzinga
,
QCOR
, and 7 more.
from
Latest Articles from Benzinga.com
Stocks Hitting 52-Week Highs
June 11, 2013
Vanda Pharmaceuticals (NASDAQ: VNDA ) shares surged 21% to touch a new 52-week high of $12.16. Vanda shares have surged 138.15% over the past 52 weeks, while the S&P 500 index has gained 24.06% in the...
Read More
category
Benzinga
,
Movers
,
52/Week Highs
, and 7 more.
from
Latest Articles from Benzinga.com
Vanda Pharmaceuticals (VNDA) gained to maintain upward trend
June 11, 2013
Vanda Pharmaceuticals (NASDAQ: VNDA) surged 8.4% to $10.89. Vanda Pharmaceuticals shares have jumped 138.15% over the past 52 weeks, while the S&P 500 index has gained 24.06% in the same period. Share...
Read More
from
BAYSTREET RSS FEED
Baker Bros. Raises Stake in Vanda Pharma (VNDA) to 13.99%
June 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8405855 for the full story.
Read More
from
StreetInsider.com News Articles
Where Is Vanda Pharmaceuticals Inc (NASDAQ:VNDA) Headed
June 10, 2013
Las Vegas, NV -- (SBWIRE) -- 06/10/2013 -- Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), a biopharmaceutical company, engages in the development and commercialization of products for the treatment of...
Read More
from
SBWire - Latest Press Releases
Fed Reassurances Boost Markets
June 06, 2013
Reassurances by the Federal Reserve that it would continue its bond buying program lifted the markets to a higher close with the Dow climbing 80 points to 15,040. Nasdaq gained 22 points to 3424.
Read More
category
Market News
from
MarketMinute.com Market Updates
Update on Corporate Activities in Stock Market (SNTA, BV, RST, VNDA)
June 06, 2013
New York, NY -- (SBWIRE) -- 06/06/2013 -- Synta Pharmaceuticals Corp. (NASDAQ: SNTA) provided Stage 2 information for its lung-cancer medication ganetespip. In premarket dealing, the inventory was...
Read More
from
SBWire - Latest Press Releases
Commit To Purchase Vanda Pharmaceuticals At $7, Earn 21.1% Annualized
June 06, 2013
Investors eyeing a purchase of Vanda Pharmaceuticals Inc (VNDA) shares, but cautious about paying the going market price of $9.27/share, might benefit from considering selling puts among the...
Read More
category
Stocks
from
Market News Video
Commit To Purchase Vanda Pharmaceuticals At $7, Earn 21.1% Annualized
June 06, 2013
Investors eyeing a purchase of Vanda Pharmaceuticals Inc (VNDA) shares, but cautious about paying the going market price of $9.27/share, might benefit from considering selling puts among the...
Read More
category
Dividends
from
Dividend Channel
Positive Findings, Collaborations, and NDA Filings Strengthen Pipelines - Research Report on Clovis Oncology, MannKind, TESARO, Peregrine Pharmaceuticals, and Vanda Pharmaceuticals
June 06, 2013
from
PR Newswire
Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
June 05, 2013
Data presented as a late breaking abstract at SLEEP 2013, the 27th Annual Meeting of Associated Professional Sleep Societies
Read More
from
PR Newswire
Increase to Improve Stocks (SHFL, VNDA, VMW, RAX)
June 05, 2013
New York City, NY -- (SBWIRE) -- 06/05/2013 -- Shuffle Master Inc. (NASDAQ:SHFL) gained $0.21 a discuss on income of $77 thousand. Experts had only predicted $0.20 and $71.6 thousand, respectively....
Read More
from
SBWire - Latest Press Releases
Big Board Most Advanced Stocks : Mhgc, Bac, Gm, Vnda
June 04, 2013
New York, NY -- (SBWIRE) -- 06/04/2013 -- Morgans Hotel Group Co. (NASDAQ:MHGC) shares gained 11.54% to $7.45. The company on June 4 said its slate of director nominees, if reelected, would consider...
Read More
from
SBWire - Latest Press Releases
Vanda Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference
May 31, 2013
Presentation will be Webcast Live and Archived on Vanda's Website
Read More
from
PR Newswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, GALE, IMMU and VNDA
May 31, 2013
from
ACCESSWIRE
Amazing Four Income Stocks: GV, KIPS, VNDA, CPRT
May 31, 2013
New York, NY -- (SBWIRE) -- 05/31/2013 -- Pennystocksondemand.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks....
Read More
from
SBWire - Latest Press Releases
NASDAQ Gainers Watch List: Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) and Pixelworks, Inc. (NASDAQ:PXLW) Added to Equity Profile Report's NASDAQ Gainers Watch List.
May 31, 2013
Wilmington, DE -- (SBWIRE) -- 05/31/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) and Pixelworks, Inc. (NASDAQ:PXLW).
Read More
from
SBWire - Latest Press Releases
Vanda Pharma (VNDA) Submits Tasimelteon NDA to U.S. FDA
May 31, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8381273 for the full story.
Read More
from
StreetInsider.com News Articles
Vanda Announces Submission To FDA Of A New Drug Application For Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally Blind
May 31, 2013
from
PR Newswire
Vanda to Present Tasimelteon Non-24 Phase III Data at Two Medical Meetings
May 30, 2013
-- Data to be presented at SLEEP 2013 27th Annual Meeting of the Associated Professional Sleep Societies and the Endocrine Society's 95th Annual Meeting
Read More
from
PR Newswire
Vanda Pharma (VNDA) Momentum Continues
May 30, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8379738 for the full story.
Read More
from
StreetInsider.com News Articles
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here